Companies /Healthcare

Anika Therapeutics Inc

NASDAQ: ANIK Drug Manufacturers - Specialty & Generic
$20.38
▼ $0.52 (−2.47%) today
Markets closed · 4:38am ET

Fundamentals

Market Cap
$272.7M
Profit Margin
-3.1%
Revenue (TTM)
$120.7M
EPS (TTM)
$-0.22
52-Week Range
$9 – $23
Street Target
$22.00

About Anika Therapeutics

Anika Therapeutics Inc is a pioneer in joint preservation, focusing on early intervention orthopedic care. With a strong foundation in hyaluronic acid (HA) technology, the company offers a range of products aimed at managing osteoarthritis pain, regenerating damaged tissues, and preserving joints. Its portfolio includes injectable pain relief solutions like Monovisc and Orthovisc, as well as innovative joint preservation technologies for both upper and lower extremities. Anika also extends its HA-based solutions to non-orthopedic applications, including wound care and ophthalmic products. Founded in 1983, Anika is based in Bedford, Massachusetts, serving customers globally.

ANIK Coverage